After hours: October 18 at 5:16 PM EDT Loading Chart for RMD ...

Many analysts see GLP-1 drugs, which have shown positive results in treating sleep apnea, as a threat to CPAP companies. But ResMed, which makes sleep apnea devices, sees an opportunity.

At close: 15 October at 5:32 pm GMT+2 ...

The MyAir consumer app. [Image courtesy of ResMed] ResMed (NYSE: RMD) + today announced new patient-centric products designed to enhance therapy for sleep apnea patients. The new innovations from ...

After hours: 15 October at 19:46 GMT-4 ...

The AirTouch N30i mask. [Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it ...

After hours: 30 September at 18:06 GMT-4 ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

Sleep apnoea devices giant ResMed wants to hit high single-digit revenue growth over the next five years broadening its product range for insomnia and COPD sufferers. The US headquartered company ...